Just Cbd Relief Soothing

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of pain. It is intended for use in patients experiencing acute pain conditions. Healthcare professionals should assess the appropriateness of this medication based on individual patient needs and the specific pain management requirements.

Dosage and Administration

For adults over 21 years of age, a small amount of the product should be applied to the affected area. The application should be followed by a gentle massage in a circular motion, allowing the product to set for a few seconds. This process may be repeated as necessary, but should not exceed 3 to 4 applications per day. The product is intended for topical use only.

Contraindications

Use is contraindicated in patients who may apply the product in large quantities, particularly over raw surfaces or blistered areas, due to the potential for adverse effects in these conditions.

Warnings and Precautions

For external use only. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and seek medical attention under the following circumstances: if redness occurs, if the condition worsens, if irritation develops, or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, medical consultation is warranted. Patients should also be instructed to report any signs of injury, including pain, swelling, or blistering at the site of application, as these may indicate a more serious reaction.

Side Effects

For external use only. Patients should discontinue use and consult a healthcare professional if any of the following adverse reactions occur: redness at the application site, worsening of the condition, development of irritation, or if symptoms persist for more than 7 days. Additionally, if symptoms clear up and then recur within a few days, patients are advised to stop use. Signs of injury, such as pain, swelling, or blistering at the site of application, also warrant immediate cessation of use and medical evaluation.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Just Cbd Relief Soothing (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

This product is intended exclusively for use by healthy adults aged 21 years and older. There is no established safety or efficacy for pediatric patients, including infants, children, and adolescents. Therefore, its use in individuals under 21 years of age is not recommended.

Geriatric Use

This product is intended solely for use by healthy adults aged 21 years and older. There is no specific information available regarding the use of this product in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when considering this product for elderly patients, as the absence of data necessitates careful evaluation of individual patient needs and potential risks. Monitoring for any adverse effects is recommended if this product is administered to geriatric patients.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice prior to use to ensure informed decision-making regarding the risks and benefits associated with this medication during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may necessitate a reduced dose of the medication. It is essential for healthcare professionals to monitor creatinine clearance in these patients to ensure appropriate dosing. Regular renal function tests should be performed to assess kidney function in patients receiving this medication. Additionally, special monitoring is required for patients with significant renal impairment to avoid potential toxicity.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial to document all findings and interventions in the patient's medical record and to report any adverse events to the appropriate regulatory authorities as required.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and contact dermatitis. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Patients should be informed to monitor for any signs of redness, irritation, or worsening of their condition. It is important to instruct patients to report if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Patients should be made aware of the signs of injury, such as pain, swelling, or blistering at the site of application, and should be instructed to discontinue use and consult a healthcare professional if these occur. Emphasize the importance of using the product only as directed and advise patients to avoid contact with the eyes. Additionally, patients should be cautioned against using the product in large quantities, especially over raw surfaces or blistered areas, to prevent potential complications.

Storage and Handling

The product is supplied in a tightly closed container to ensure stability and integrity. It should be stored in a dry place at controlled room temperature, specifically between 59ºF and 86ºF (15ºC to 30ºC). Proper storage conditions are essential to maintain the product's efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Just Cbd Relief Soothing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)